Abstract
Keywords
References
Visha MG. Selective Cox-2 inhibitor. Int J Pharm Sci Interv. 2013;3(2):28–33.
Ferreira SH. Inflammatory pain: the role of cytokines and its control by drugs which release nitric oxide. Ann Ist Super Sanita.1993;29(3):367–373.
Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267–84.
Percival M. Understanding the natural management of pain and inflammation. Clin Nutr Insight.1997;30:1–5.
Zarghi A, Zebardast T, Daraie B, Hedayati M. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Bioorg Med Chem.2009;17:5369–5373.
Zarghi A, Arefi H, Dadrass OG, Torabi S. Design and synthesis of new 2-aryl, 3-benzyl-(1,3-oxazolidine or 1,3-thiazolidine)-4-ones as selective cyclooxygenase (COX-2) inhibitors. Med Chem Res. 2010;19:782–793.
Zarghi A, Arfaei S. Selective Cox-2 inhibitors: a review of their structure-activity relationships. Iran J Pharm Res. 2011;10(4): 655–683.
Patel NB. Physiology of pain. 2010. Accessed from: https://www. uonbi.ac.ke/npatel/files/chapter_3_physiology_of_pain_.pdf
Marchand S. The physiology of pain mechanisms: from the periphery to the brain. Rheum Dis Clin North Am. 2008;34:285–309.
Fein A. Nociceptors and the perception of pain. 2012. Accessed from: http://cell.uchc.edu/pdf/fein/nociceptors_fein_2012.pdf
Jaggar SI. Overview of pain pathways. In: Holdcroft A, Jaggar S (eds): Core topics in pain. New York: Cambridge University Press;2005. pp. 3–5.
Melzack R, Wall PD. Pain mechanisms: a new theory. Science.1965;150:971–979.
Cafferty W. Peripheral mechanisms. In: Holdcroft A, Jaggar S (eds): Core topics in pain. New York: Cambridge University Press;2005. pp. 8–15.
Echeverry S, Lee SH, Lim T, Zhang J. Contribution of inflammation to chronic pain triggered by nerve injury. 2012. Accessed from: http://cdn.intechopen.com/pdfs-wm/34132.pdf
Ferreira SH, Nakamura M. I-prostaglandin hyperalgesia: a cAMP/ Ca++ dependent process. Prostaglandins. 1979;18:179–190.
Finnerup NB, Jensen TS. Nerve damage and its relationship to neuropathic pain. In: Holdcroft A, Jaggar S (eds): Core topics in pain. New York: Cambridge University Press; 2005. pp. 43–47.
Farquhar-Smith WP, Kerr BJ. Inflammation and pain. In: Holdcroft A, Jaggar S (eds): Core topics in pain. New York: Cambridge University Press; 2005. pp. 37–41.
DeLeo JA, Yezierski RP. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain. 2001;90:1–6.
Boddeke EW. Involvement of chemokines in pain. Eur J Pharmacol. 2001;429:115–119.
Burnstock G. P2X receptors in sensory neurones. Br J Anaesth. 2000;84:476–488.
Waldron JB, Sawynok J. Peripheral P2X receptors and nociception: interactions with biogenic amine systems. Pain. 2004;110:79–89.
Hawkins PT, Stephens LR. PI3K signaling in inflammation. Biochim Biophys Acta. 2015;185:1882–1889.
Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428–435.
Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13:159–175.
Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated.Nat Rev Immunol. 2007;7:678–689.
Samad TA, Sapirstein A, Woolf CJ. Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med. 2002;8:390–396.
Fiorucci S, Meli R, Bucci M, Cirino G. Dual inhibitors of cyclooxygenase and 5-lipoxygenase: a new avenue in anti-inflammatory therapy. Biochem Pharmacol. 2001;62:1433–1438.
Claria J. Cyclooxygenase-2 biology. Curr Pharm Des. 2003;9: 2177–2190.
Uddin MJ, Rao PNP, McDonald R, Knaus EE. Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase- 2 (COX-2) isozyme. Bioorg Med Chem Lett. 2005;15:439–442.
Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 1971;231:232–235.
Hata AN, Breyer RM. Pharmacology and signalling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther. 2004;03:147–166.
Charlier C, Michaux C. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. Eur J Med Chem. 2003;38:645–659.
Dannhardt G, Kiefer W. Cyclooxygenase inhibitors current status and future prospects. Eur J Med Chem. 2001;36:109–126.
Brock TG. Regulating leukotriene synthesis: the role of nuclear 5-lipoxygenase. J Cell Biochem. 2005;96:1203–1211.
Wisastra R, Dekker FJ. Inflammation, cancer, oxidative lipoxygenase activity are intimately linked. Cancers. 2014;6:1500–1521.
Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol. 2010;177:1576–1591.
Noiri E, Yokomizo T, Nakao A, Izumi T, Fujita T, Kimura S et al. An in vivo approach showing the chemotactic activity of leukotriene B4 in acute renal ischemic-reperfusion injury. Proc Nat Acad Sci. 2000;18:823–828.
Nowsheen K, Aziz TB, Kryston NF, Ferguson NF, Georgakilas A. The interplay between inflammation and oxidative stress and carcinogenesis. Curr Mol Med. 2012;12:672–680.
Lawerance T. The nuclear factor NF-?B pathway in inflammation. CSH Perspect. Biol. 2009;1(6):a001651.
Govindappa M, Sadananda TS, Channabasava R, Raghavendra VB. In vitro anti-inflammatory, lipoxygenase, xanthine oxidase and acetycholinesterase inhibitory activity of Tecoma stans (l.) Juss. Ex kunth. Int J Pharm Biosci. 2011;2(2):275–285.
Harris RC, Breyer MD. Update on cyclooxygenase-2 inhibitors. Clin J Am Soc Nephrol. 2006;1:236–245.
Katori M, Majima M. Cyclooxygenase-2: its rich diversity roles and possible application of its selective inhibitors. Inflamm Res. 2000;49:367–392.
Kuhn H, O’Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 2006;45:334–356.
Alvero-Gracia JM. Licofelone-clinical update on a novel LOX/ COX inhibitor for the treatment osteoarthritis. Rheumatology.2004;43:i21–i25.
Chen QH, Rao PNP, Knaus EE. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs). Bioorg Med Chem Lett. 2006;14:7898–7909.
Ye W, Zhang H, Hillas E, Kohan DE, Miller RL, Nelson RD, et al. Expression and function of COX isoforms in renal medulla: evidence for regulation of salt sensitivity and blood pressure. Am J Physiol Renal Physiol. 2006;290:F542–F549.
Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 1996;384: 644–648.
Lima GRM, Montenegro CA, Almeida CLF, Athayde-Filho PF, Barbosa-Filho JM, Batista LM. Database survey of anti-inflammatory plants in South America: a review. Int J Mol Sci. 2011;12:2692–2749.
Kumar S, Bajwa BS, Kuldeep S, Kalia AN. Anti-inflammatory activity of herbal plants: a review. Int J Adv Pharm Biol Chem. 2013;2(2):272–281.
Murugesan D, Deviponnuswamy R. Potential anti-inflammatory medicinal plants: a review. Int J Pharm Pharm Sci. 2014;6(4):43–49.
Chi Y, Jong H, Son K, Chang H, Kang S, Kim H. Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases. Biochem Pharmacol. 2001;62:1185–1191.
Aganihotri S, Wakode S, Aganihotri A. An overview on anti-inflammatory properties and chemo-profiles of plants used in traditional medicine. Indian J Nat Prod Res. 2010;1(2):150–167.
Chrubasik S, Eisenberg E, Balan E, Weinberger T, Luzzati R, Conradt C. Treatment of low back pain exacerbations with willow bark extracts: a randomized double-blind study. Am J Med. 2000;109(1):9–14.
Cobiac L, Clifton PM, Abbey M, Belling GB, Nestel PJ. Lipid, lipoprotein, and hemostatic effects of fish vs. fish-oil n-3 fatty acids in mildly hyperlipidemic males. Am J Clin Nutr. 1991;53:1210–1216.
Olaleye SB, Oke JM, Etu AK, Omotosho IO, Elegbe RA. Antioxidant and anti-inflammatory properties of a flavonoid fraction from the leaves of voacanga Africana. Niger J Physiol Sci. 2004;19(1–2):69–76.
Hemamalini K, Naik KOM, Ashok P. Anti-inflammatory and analgesic effect of methanolic extract of Anogeissus acuminata leaf. Int J Pharm Biomed Res. 2010;1(3):98–101.
Vieira-de-Sousa O, Vieira GD, Jesus J, Pinho RG, Yamamoto CH, Alves MS. Antinociceptive and anti-inflammatory activities of the ethanol extract of Annonamuricata L. leaves in animal models. Int J Mol Sci. 2010;11(5):2067–2078.
Leboeuf M, Cavé A, Bhaumik PK, Mukherjee B, Mukherjee R. The phytochemistry of the annonaceae. Phytochemistry. 1982;21:2783–2813.
Kantamreddi VSSN, Lakshmi YN, Kasapu VVVS. Preliminary phytochemical analysis of some important Indian plant species. Int J Pharm Bio Sci. 2010;1(4):351–358.
Ayoola GA, Folawewo AD, Adesegun SA, Abioro OO, Adepoju- Bello AA, Coker HAB. Phytochemical and antioxidant screening of some plants of apocynaceae from South West Nigeria. African J Plant Sci. 2008;2(9):124–128.
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.